Welcome to the Institute of Molecular Medicine, Trinity College Dublin
Institute of Molecular Medicine - Front Entrance
Institute of Molecular Medicine, view from St. James's Street
The Institute of Molecular Medicine (IMM) is part of a groundbreaking research partnership in Molecular Medicine between Trinity College Dublin, University College Dublin and Royal College of Surgeons in Ireland. IMM represents Trinity College Dublin in this unique collaboration, spearheaded by the Dublin Molecular Medicine Centre.
Situated on the St James’s Hospital campus, IMM is a 4,500 mē state-of-the-art facility dedicated to research into the molecular basis of human disease. This multidisciplinary research institute was completed in early 2003 and currently houses 19 research teams consisting approximately 130 residents. IMM was officially opened on November 7th, 2003 by the Minister for Education & Science, Noel Dempsey, TD.
The development of IMM is funded by the Higher Education Authority’s Programme for Research in Third Level Institutions (PRTLI). IMM provides a centre for collaborative molecular medicine research, linking directly with areas of research into cancer, leukaemia and the molecular basis of disease, providing a major contribution to graduate education in the life sciences.
There's a need to understand the functions of all of the sequenced genes and to understand how these functions can go wrong in the development of human disease. This process will best be served by a critical mass of high quality biomolecular and biomedical researchers closely affiliated to clinical centres of excellence. The opening of the IMM at Trinity's St James's Hospital campus allows this synergy to take place on a major teaching hospital site in Dublin.
The IMM in collaboration with the DMMC aims to fuel Irish drug discovery and biotechnology ventures, and attract pharmaceutical contract R & D research to Ireland. An Enterprise Ireland grant has been awarded to develop a bio-incubator facility on this site, which will permit rapid translation of the results of bench science to development of products of use in the diagnosis and treatment of disease. A number of new companies are in process as a result of IMM/DMMC research which have the potential to generate new strengths in the Irish economy in addition to providing for enhanced patient care.